Clinical Trial Update: Cerebrospinal Fluid Biomarkers for Brain Tumors

View source ↗

Summary

A Mayo Clinic-sponsored clinical trial is investigating cerebrospinal fluid biomarkers for brain tumors and is currently recruiting participants.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Neoplasms

Snippet

Sponsor: Mayo Clinic | Conditions: Central Nervous System Neoplasm | Status: RECRUITING